Abingdon Health (LON:ABDX) Shares Climb 5.6% – Here’s Why

Abingdon Health Plc (LON:ABDX)’s share price traded up 5.6% during trading on Wednesday. The stock traded as high as GBX 9.50 and last traded at GBX 9.50. Approximately 12,604 shares were traded during trading, a decline of 94% from the average session volume of 223,199 shares. The stock had previously closed at GBX 9.

Abingdon Health Stock Performance

The company has a debt-to-equity ratio of 21.99, a quick ratio of 1.96 and a current ratio of 1.91. The stock’s fifty day moving average is GBX 10.12 and its two-hundred day moving average is GBX 9.51. The firm has a market cap of £21.99 million, a price-to-earnings ratio of -10.74 and a beta of 0.13.

Abingdon Health (LON:ABDX) last issued its quarterly earnings data on Tuesday, October 13th. The company reported GBX (0.51) earnings per share for the quarter. Abingdon Health had a negative net margin of 19.36% and a negative return on equity of 34.31%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.